Search
GE Healthcare Technologies Inc
GEHCAdd to Watchlist
61.700USD
-1.770-2.79%
Close 05/11, 16:00（ET）Quotes delayed by 15 min
28.07BMarket Cap
14.73P/E TTM
More Details of GE Healthcare Technologies Inc Company
GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
GE Healthcare Technologies Inc Info
Ticker SymbolGEHC
Company nameGE Healthcare Technologies Inc
IPO dateDec 15, 2022
CEOBankes (Jeannette)
Number of employees53000
Security typeOrdinary Share
Fiscal year-endDec 15
Address500 West Monroe Street
CityCHICAGO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code60661
Phone18337351139
Websitehttps://www.gehealthcare.com
Ticker SymbolGEHC
IPO dateDec 15, 2022
CEOBankes (Jeannette)
Company Executives of GE Healthcare Technologies Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Peter J. Arduini
Mr. Peter J. Arduini
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
514.49K
+0.81%
Mr. Roland Rott
Mr. Roland Rott
President and CEO - Imaging
President and CEO - Imaging
76.89K
+11.15%
Mr. Kenneth Robert (Ken) Stacherski
Mr. Kenneth Robert (Ken) Stacherski
Chief Global Supply Chain and Service Officer
Chief Global Supply Chain and Service Officer
41.00K
-2.18%
Mr. William J. Stromberg
Mr. William J. Stromberg
Independent Director
Independent Director
15.33K
+6.52%
Dr. Rodney F. Hochman
Dr. Rodney F. Hochman
Independent Director
Independent Director
13.61K
--
Ms. Anne T. Madden
Ms. Anne T. Madden
Independent Director
Independent Director
13.61K
--
Dr. Risa J. Lavizzo-Mourey, M.D.
Dr. Risa J. Lavizzo-Mourey, M.D.
Lead Independent Director
Lead Independent Director
10.16K
--
Dr. Tomislav Mihaljevic, M.D.
Dr. Tomislav Mihaljevic, M.D.
Independent Director
Independent Director
9.12K
--
Mr. Frank R. Jimenez
Mr. Frank R. Jimenez
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Mr. Kevin Michael O'Neill
Mr. Kevin Michael O'Neill
Chief Executive Officer - Pharmaceutical Diagnostics
Chief Executive Officer - Pharmaceutical Diagnostics
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Peter J. Arduini
Mr. Peter J. Arduini
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
514.49K
+0.81%
Mr. Roland Rott
Mr. Roland Rott
President and CEO - Imaging
President and CEO - Imaging
76.89K
+11.15%
Mr. Kenneth Robert (Ken) Stacherski
Mr. Kenneth Robert (Ken) Stacherski
Chief Global Supply Chain and Service Officer
Chief Global Supply Chain and Service Officer
41.00K
-2.18%
Mr. William J. Stromberg
Mr. William J. Stromberg
Independent Director
Independent Director
15.33K
+6.52%
Dr. Rodney F. Hochman
Dr. Rodney F. Hochman
Independent Director
Independent Director
13.61K
--
Ms. Anne T. Madden
Ms. Anne T. Madden
Independent Director
Independent Director
13.61K
--
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q1
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Total Imaging
9.24B
44.82%
Total Ultrasound
5.35B
25.96%
Total PCS
3.09B
14.96%
Total PDx
2.90B
14.06%
Other
40.00M
0.19%
By RegionUSD
Name
Revenue
Proportion
Other
9.43B
45.71%
United States
9.17B
44.45%
China
2.03B
9.85%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Total Imaging
9.24B
44.82%
Total Ultrasound
5.35B
25.96%
Total PCS
3.09B
14.96%
Total PDx
2.90B
14.06%
Other
40.00M
0.19%
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Dodge & Cox
6.86%
Vanguard Capital Management, LLC
6.35%
Capital Research Global Investors
5.58%
BlackRock Institutional Trust Company, N.A.
5.48%
State Street Investment Management (US)
4.41%
Other
71.33%
Shareholders
Shareholders
Proportion
Dodge & Cox
6.86%
Vanguard Capital Management, LLC
6.35%
Capital Research Global Investors
5.58%
BlackRock Institutional Trust Company, N.A.
5.48%
State Street Investment Management (US)
4.41%
Other
71.33%
Shareholder Types
Shareholders
Proportion
Investment Advisor
49.86%
Investment Advisor/Hedge Fund
30.52%
Research Firm
2.97%
Hedge Fund
2.93%
Pension Fund
2.88%
Sovereign Wealth Fund
1.96%
Bank and Trust
1.27%
Insurance Company
0.97%
Individual Investor
0.36%
Other
6.28%
Institutional Shareholding
Updated: Sun, Apr 5
Updated: Sun, Apr 5
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
2487
425.83M
93.61%
-8.40M
2025Q4
2310
400.60M
85.71%
--
2025Q3
2366
400.81M
86.07%
+553.52K
2025Q2
2431
400.55M
88.05%
+24.13M
2025Q1
2426
405.65M
95.66%
-32.34M
2024Q4
2331
419.80M
91.27%
+20.88M
2024Q3
2167
398.38M
86.23%
+22.39M
2024Q2
2063
375.84M
84.85%
+4.36M
2024Q1
1976
370.75M
77.53%
+16.94M
2023Q4
1833
338.14M
75.18%
+5.23M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Dodge & Cox
31.21M
6.84%
+3.69M
+13.42%
Dec 31, 2025
Capital Research Global Investors
25.36M
5.56%
+389.80K
+1.56%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
24.94M
5.47%
+283.21K
+1.15%
Dec 31, 2025
State Street Investment Management (US)
20.05M
4.39%
+401.93K
+2.05%
Dec 31, 2025
Harris Associates L.P.
15.85M
3.47%
+4.83M
+43.85%
Dec 31, 2025
Geode Capital Management, L.L.C.
12.11M
2.65%
+37.16K
+0.31%
Dec 31, 2025
Invesco Capital Management (QQQ Trust)
9.68M
2.12%
-237.70K
-2.40%
Feb 28, 2026
Hotchkis and Wiley Capital Management, LLC
9.03M
1.98%
+600.37K
+7.12%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Invesco S&P Spin-Off ETF
7.25%
Global X HealthTech ETF
4.14%
iShares U.S. Medical Devices ETF
4.07%
Absolute Select Value ETF
2.89%
VanEck Morningstar Wide Moat ETF
2.36%
Knowledge Leaders Developed World ETF
2.22%
Invesco Zacks Mid-Cap ETF
1.91%
Simplify Health Care ETF
1.77%
State Street SPDR S&P Health Care Equipment ETF
1.76%
First Trust NASDAQ-100 Ex-Technology Sector Index Fund
1.75%
View more
Invesco S&P Spin-Off ETF
Proportion7.25%
Global X HealthTech ETF
Proportion4.14%
iShares U.S. Medical Devices ETF
Proportion4.07%
Absolute Select Value ETF
Proportion2.89%
VanEck Morningstar Wide Moat ETF
Proportion2.36%
Knowledge Leaders Developed World ETF
Proportion2.22%
Invesco Zacks Mid-Cap ETF
Proportion1.91%
Simplify Health Care ETF
Proportion1.77%
State Street SPDR S&P Health Care Equipment ETF
Proportion1.76%
First Trust NASDAQ-100 Ex-Technology Sector Index Fund
Proportion1.75%
Dividend
A total of
96.00M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Feb 12, 2026
GEHC.NB Interim Cash Dividend of gross USD 0.035 paid on May 15, 2026 going ex on Apr 02, 2026
Apr 03, 2026
May 15, 2026
Apr 02, 2026
Nov 24, 2025
GEHC.NB Final Cash Dividend of gross USD 0.035 paid on Feb 13, 2026 going ex on Jan 09, 2026
Jan 09, 2026
Feb 13, 2026
Jan 09, 2026
Sep 24, 2025
GEHC.NB Interim Cash Dividend of gross USD 0.035 paid on Nov 14, 2025 going ex on Oct 24, 2025
Oct 24, 2025
Nov 14, 2025
Oct 24, 2025
Jul 01, 2025
GEHC.NB Interim Cash Dividend of gross USD 0.035 paid on Aug 15, 2025 going ex on Jul 25, 2025
Jul 25, 2025
Aug 15, 2025
Jul 25, 2025
Mar 27, 2025
GEHC.NB Interim Cash Dividend of gross USD 0.035 paid on May 15, 2025 going ex on Apr 25, 2025
Apr 25, 2025
May 15, 2025
Apr 25, 2025
Nov 21, 2024
GEHC.NB Final Cash Dividend of gross USD 0.035 paid on Feb 14, 2025 going ex on Jan 14, 2025
Jan 14, 2025
Feb 14, 2025
Jan 14, 2025
Sep 18, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Nov 15, 2024 going ex on Oct 18, 2024
Oct 18, 2024
Nov 15, 2024
Oct 18, 2024
Jun 26, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 15, 2024 going ex on Jul 19, 2024
Jul 19, 2024
Aug 15, 2024
Jul 19, 2024
Mar 22, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on May 15, 2024 going ex on Apr 18, 2024
Apr 19, 2024
May 15, 2024
Apr 18, 2024
Dec 08, 2023
GEHC.NB Final Cash Dividend of gross USD 0.03 paid on Feb 15, 2024 going ex on Jan 12, 2024
Jan 16, 2024
Feb 15, 2024
Jan 12, 2024
View more
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
